The Pavilion at University of Michigan Health will be the name of the new Michigan Medicine hospital currently under construction, the University of Michigan’s academic medical center announced today.

Women have borne a disproportionate burden during the COVID-19 pandemic, and women in medicine are no exception. Can we seize this disruptive opportunity to improve gender equity in medicine?

Opioid pain medication carries risks

In 25 years, Chris Cauley had never taken two weeks off of work. As health services were shutting down because of COVID-19, he had to learn how to be a patient.

People with the condition risk fracture more than the general population, but the timing raises new questions.

New technique visualizes all gene expression from a tissue.

Pandemic alcohol use has gotten a lot of attention but new poll data show problematic drinking by many older adults.

People with obesity also needed these common interventional cardiology procedures earlier than those who were not obese, in a new study from across the state of Michigan.

Physician assistants represented by the United Physician Assistants of Michigan Medicine/AFT 5297 (UPAMM) have ratified a three-year contract with Michigan Medicine, the academic medical center of the University of Michigan.

Maintaining a healthy brain is another good reason people can take action on diet, blood pressure, exercise, alcohol, social interaction and more.

One patient transcends her ‘moat’ against COVID-19 while her art therapist finds unexpected benefits to teaching online.

Non-veterans with COVID-19 found themselves in veterans’ hospitals during the past year, setting a precedent for future national crises.

A research team from Michigan Medicine has developed a new potential treatment for fatty liver disease in patients with partial lipodystrophy and/or NASH.

The University of Michigan will launch a new Institute for Firearm Injury Prevention to generate knowledge and advance innovative solutions that reduce firearm injury, a public health crisis that leads to more than 100 deaths per day across the United States.

Findings offer clues to why some types of renal cell carcinoma respond to immunotherapy while others do not.